Hepatitis C virus causes severe liver disease. Initial trials of a newly developed agent that prevents the virus reproducing itself look promising. But what are the future prospects for this treatment?
This is a preview of subscription content, log in via an institution to check access.
References
Lamarre, D. et al. Nature doi:10.1038/nature02099 (2003).
Lanford, R. E. & Bigger, C. Virology 293, 1–9 (2002).
Mercer, D. F. et al. Nature Med. 7, 927–933 (2001).
Lohmann, V. et al. Science 285, 110–113 (1999).
Blight, K. J., Kolykhalov, A. A. & Rice, C. M. Science 290, 1972–1974 (2000).
Bartosch, B., Dubuisson, J. & Cosset, F. L. J. Exp. Med. 197, 633–642 (2003).
Hsu, M. et al. Proc. Natl Acad. Sci. USA 100, 7271–7276 (2003).
Kolykhalov, A. A., Mihalik, K., Feinstone, S. M. & Rice, C. M. J. Virol. 74, 2046–2051 (2000).
Kim, J. L. et al. Cell 87, 343–355 (1996).
Love, R. A. et al. Cell 87, 331–342 (1996).
Llinàs-Brunet, M. et al. Bioorg. Med. Chem. Lett. 8, 1713–1718 (1998).
Steinkühler, C. et al. Biochemistry 37, 8899–8905 (1998).
Trozzi, C. et al. J. Virol. 77, 3669–3679 (2003).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Rice, C. Fresh assault on hepatitis C. Nature 426, 129–131 (2003). https://doi.org/10.1038/nature02105
Published:
Issue Date:
DOI: https://doi.org/10.1038/nature02105
- Springer Nature Limited